Clinical Trials Browser

Phase 1/2 × UNKNOWN × Neoplasm Metastasis × Clear all

NCT04380103 2020-05-08

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms